SAE Reconciliation Issues Between Sites and Sponsors Noted in Audits
SAE Reconciliation Issues Between Sites and Sponsors Noted in Audits SAE Reconciliation Gaps in Clinical Trial Audit Findings Introduction: The Criticality of SAE Reconciliation Serious Adverse Event (SAE) reconciliation is the process of ensuring that safety data recorded at investigator sites is consistent with sponsor pharmacovigilance databases. It is a fundamental expectation of ICH E2A,…
Read More “SAE Reconciliation Issues Between Sites and Sponsors Noted in Audits” »